At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BEAT Heartbeam Inc
Trading 03-06 13:43:35 EST
2.13
+0.02
+0.95%
| High2.17 | Low2.05 | Vol51.49K |
| Open2.17 | D1 Closing2.11 | Amplitude5.80% |
| Mkt Cap69.99M | Tradable Cap55.55M | Total Shares32.86M |
| T/O110.32K | T/O Rate0.20% | Tradable Shares26.08M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
Business Wire · 14:01
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
Business Wire · 02-27
Heartbeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
THOMSON REUTERS · 02-25
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
Business Wire · 02-25
Heartbeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
THOMSON REUTERS · 02-13
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
Business Wire · 02-13
Heartbeam : Submitted a 510(K) Application to U.S. FDA for Co's 12-Lead Electrocardiogram (Ecg) Synthesis Software
THOMSON REUTERS · 01-29
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
Business Wire · 01-29
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
Business Wire · 2024-12-23
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
Heartbeam Inc Files for Common Stock Offering of up to $10 Mln - SEC Filing
THOMSON REUTERS · 2024-12-23
BUZZ-HeartBeam rises on FDA clearance for heart-monitoring device
Reuters · 2024-12-16
HeartBeam's Heart Monitoring Device Receives US FDA Clearance
MT Newswires Live · 2024-12-16
HeartBeam announces FDA clearance for high-fidelity ECG system
TIPRANKS · 2024-12-16
Heartbeam Shares up 17.3% Premarket on FDA Clearance of Co's Heart Monitoring Device
THOMSON REUTERS · 2024-12-16
Heartbeam Announces FDA Clearance for at-Home, High-Fidelity Heart Monitoring Technology
THOMSON REUTERS · 2024-12-16
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
Business Wire · 2024-12-16
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
Business Wire · 2024-11-19
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
Heartbeam Price Target Maintained With a $8.00/Share by Benchmark
Dow Jones · 2024-11-15
HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...
GuruFocus.com · 2024-11-08
Heartbeam Inc reports results for the quarter - Earnings Summary
Reuters · 2024-11-08
Introduction
Company Name.
Heartbeam Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App